Clinical Trial Update: Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

View source ↗

Summary

A recruiting clinical trial evaluating whether adding chemotherapy or an androgen receptor–targeting agent (alone or with radiotherapy) to androgen deprivation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Metastatic Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Santa Chiara Hospital | Conditions: Prostate Cancer, Hormone Sensitive Prostate Cancer | Status: RECRUITING